A detailed history of Nissay Asset Management Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Nissay Asset Management Corp holds 5,841 shares of CRL stock, worth $1.36 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,841
Previous 5,749 1.6%
Holding current value
$1.36 Million
Previous $1.36 Million 16.41%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$203.52 - $273.43 $18,723 - $25,155
92 Added 1.6%
5,841 $1.58 Million
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $36,687 - $53,261
223 Added 4.04%
5,749 $1.36 Million
Q3 2023

Nov 14, 2023

BUY
$194.44 - $217.61 $36,165 - $40,475
186 Added 3.48%
5,526 $1.08 Million
Q2 2023

Aug 14, 2023

SELL
$183.71 - $210.25 $6,613 - $7,569
-36 Reduced 0.67%
5,340 $1.12 Million
Q1 2023

May 15, 2023

SELL
$191.89 - $259.92 $34,732 - $47,045
-181 Reduced 3.26%
5,376 $1.08 Million
Q4 2022

Feb 14, 2023

SELL
$197.11 - $250.07 $21,879 - $27,757
-111 Reduced 1.96%
5,557 $1.21 Million
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $43,603 - $59,879
239 Added 4.4%
5,668 $1.12 Million
Q2 2022

Aug 15, 2022

SELL
$204.13 - $302.4 $34,293 - $50,803
-168 Reduced 3.0%
5,429 $1.16 Million
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $34,749 - $49,246
136 Added 2.49%
5,597 $1.59 Million
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $37,597 - $48,008
107 Added 2.0%
5,461 $2.06 Million
Q3 2021

Nov 10, 2021

BUY
$372.64 - $458.3 $70,056 - $86,160
188 Added 3.64%
5,354 $2.21 Million
Q2 2021

Aug 13, 2021

BUY
$294.17 - $371.65 $1.52 Million - $1.92 Million
5,166 New
5,166 $1.91 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $11.9B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Nissay Asset Management Corp Portfolio

Follow Nissay Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.